Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection

NCT05754762 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05754762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2023
Completion date
July 1, 2023
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

etomidate, myoclonus